June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

US FDA tested retail milk samples for bird flu in 17 states

Published 05/20/2024, 02:22 PM
Updated 05/20/2024, 02:25 PM
© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

(Reuters) - The U.S. Food and Drug Administration said on Monday that it tested retail samples of milk and other dairy products in 17 states for viable bird flu virus, providing further details about the locations of the previously disclosed tests.

The regulator said it collected 297 samples at retail locations in 17 states between April 18-22, but the retail samples represented products made at 132 processing locations in 38 states.

   "Even if a sample was collected in one particular state, the milk in a consumer package could have come from cows on several farms located in several states, pasteurized in a different state from where the milk was produced, and available for purchase in yet another state," the agency said in its statement.

The U.S. has confirmed bird flu in dairy cattle in nine states since late March.

The FDA had said on May 10 that no live virus was found in retail milk samples. It has also said that pasteurized milk is safe to drink but has cautioned against consuming raw milk.

© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

Scientists, however, have said they believe the outbreak is more widespread based on the FDA's findings that showed about 20% of retail milk samples contained remnants of the H5N1 virus.

The samples included cottage cheese, cream, and half and half, which is equal parts milk and cream, sour cream and yoghurt, in addition to milk.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.